Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air® DOI Creative Commons
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó

et al.

Clinical and Translational Allergy, Journal Year: 2024, Volume and Issue: 14(9)

Published: Sept. 1, 2024

Language: Английский

MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases DOI Creative Commons
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(8), P. 2010 - 2016.e7

Published: March 22, 2024

In the recent report of Organisation for Economic Co-operation and Development (OECD) on Best Practices (BPs) Integrating Care to Prevent Manage Chronic Diseases, an app rhinitis asthma (MASK-air [Mobile Airways Sentinel networK airway diseases]) has been listed. The OECD is a reliable source evidence-based policy analysis economic data largely used by governments. It published several BPs public health. On May 10, 2023, 13 Diseases in European Union. did not cover all models integrated care; rather, it "focuse(d) those that are key strategic interest makers." New MASK-air studies (not report) include equity, usability old-age adults, impact, quality life, allergen immunotherapy. freely available iOS Android 30 countries recently introduced United States. BP represents model digitally enabled, patient-centered care chronic diseases using holistic approach shared decision making.

Language: Английский

Citations

8
Impact of allergic symptoms on work productivity in allergic rhinitis: A MASK-air direct patient data study DOI Creative Commons
Rafael José Vieira, Ana Margarida Pereira, Maciej Kupczyk

et al.

Allergology International, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Allergic rhinitis may impair work productivity. This study aimed to assess (i) the differential impact of allergic symptoms on performance, assessed by means Visual Analogue Scale (VAS) work; and (ii) effect asthma comorbidity We data from MASK-air mHealth app patients with rhinitis. identified factors associated productivity through multivariable linear mixed effects models. studied 260,378 days 20,724 patients. In regression models, nasal showed strongest association VAS (regression coefficient = 0.38 [95%CI 0.38; 0.38]). Poor control, measured combined symptom-medication score, was worse 0.96 0.96; 0.97]). The median in probable or possible (median 9, interquartile range 22 for 23 asthma) greater than no evidence 3, 12) (Cohen's d 0.60). asthma, a similar nose 0.32 0.31; 0.32]; 0.30 0.29; 0.31]). Allergy symptoms, especially are addition, display more impairment alone.

Language: Английский

Citations

0
Reply DOI

Emily A Dzoba,

Chang‐Gyu Jung, Seong Cho

et al.

Journal of Allergy and Clinical Immunology, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Citations

0
From “one airway, one disease” to “one airway, many diseases” DOI
Jean Bousquet,

Josep M Antó,

Tari Haahtela

et al.

Journal of Allergy and Clinical Immunology, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0
Rhinitis Phenotypes Based on Multimorbidities DOI
Álvaro A. Cruz,

Jean Bousquet

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(6), P. 1487 - 1489

Published: April 17, 2024

Language: Английский

Citations

2
Impact of allergic rhinitis control on work productivity and costs: a real-world data MASK-air study DOI
Rafael José Vieira, Luís Filipe Azevedo, Ana Margarida Pereira

et al.

The Journal of Allergy and Clinical Immunology In Practice, Journal Year: 2024, Volume and Issue: 12(11), P. 3107 - 3115.e13

Published: Aug. 5, 2024

Language: Английский

Citations

2
Contribution of MASK-air® as a mHealth tool for digitally-enabled person-centred care in rhinitis and asthma DOI Open Access
Bernardo Sousa‐Pinto,

JA Fonseca,

Jean Bousquet

et al.

Journal of Investigational Allergology and Clinical Immunology, Journal Year: 2024, Volume and Issue: 34(3), P. 148 - 156

Published: May 14, 2024

In chronic diseases, mHealth apps help to improve clinical management and provide valuable real-world scientific evidence. allergic rhinitis, a market research study identified only 4 that were multilingual, resulted in publications, displayed comprehensive list of medications. Of these apps, MASK-air® generated the highest number publications. MASK-air was launched 2015 is currently available 30 countries, with data collected from more than 000 users. It comprises daily monitoring questionnaire, enabling patients register their allergy symptoms by means visual analog scales medication use. The achievements include development 2 digital biomarkers for rhinitis asthma (combined symptom-medication score electronic control score). have also made it possible assess patients’ behavior, suggesting do not follow guideline recommendations, but rather treat themselves (and often use comedication) when they feel worse. Using data, we quantified impact diseases on quality life school work productivity. Realworld are being used as source evidence Allergic Rhinitis its Impact Asthma 2024 guidelines an innovative process incorporation mobile health into guidelines. This review discusses contributions person-centred care asthma, providing illustrative example diseases.

Language: Английский

Citations

1
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air® DOI Creative Commons
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó

et al.

Clinical and Translational Allergy, Journal Year: 2024, Volume and Issue: 14(9)

Published: Sept. 1, 2024

Language: Английский

Citations

1